跳转至内容
Merck
CN
  • Topical and systemic therapies for oral and perioral herpes simplex virus infections.

Topical and systemic therapies for oral and perioral herpes simplex virus infections.

Journal of the California Dental Association (2013-05-28)
Eric T Stoopler, Ramesh Balasubramaniam
摘要

Oral and perioral herpes simplex virus (HSV) infections in healthy individuals often present with signs and symptoms that are clearly recognized by oral health care providers (OHCPs). Management of these infections is dependent upon a variety of factors and several agents may be used for treatment to accelerate healing and decrease symptoms associated with lesions. This article will review the pertinent aspects of topical and systemic therapies of HSV infections for the OHCP.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
L -缬氨酸, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L -缬氨酸, reagent grade, ≥98% (HPLC)
SAFC
L -缬氨酸
Supelco
阿昔洛韦, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L -缬氨酸, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
2-氨基嘌呤, ≥99%
Supelco
L-缬氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
伐昔洛韦 盐酸盐 水合物, ≥98% (HPLC), solid
Sigma-Aldrich
阿昔洛韦, ≥99% (HPLC), powder
阿昔洛韦, European Pharmacopoeia (EP) Reference Standard
Supelco
L -缬氨酸, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
泛昔洛韦, ≥98% (HPLC)